Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Louise Ward
Observed names:
L Ward,
L. Ward
Institutions:
Newcastle upon Tyne Hospitals NHS Foundation Trust,
Newcastle University
Observed institutions:
Children's Hospital of Eastern Ontario,
Newcastle upon Tyne Hospitals NHS Foundation Trust,
Newcastle University
ORCID:
0009-0009-5078-6375
Observed ORCID:
0009-0009-5078-6375
OpenAlex ID:
A5110834784
Modeling of Dysferlinopathy (LGMDR2) Progression
2025
·
Carla Florencia Bolano-Diaz
, Harmen Reyngoudt
, et al.
·
Neurology Genetics
·
6
PDF
P.71 Vamorolone has less impact than daily prednisone or deflazacort on height and body mass index in patients with Duchenne muscular dystrophy (DMD)
2022
·
L. Ward
, V. Rao
, et al.
·
Neuromuscular Disorders
·
3
FP.03 The spine fracture burden in boys with DMD treated with the novel dissociative steroid vamorolone versus deflazacort and prednisone
2022
·
L. Ward
, S. Jackowski
, et al.
·
Neuromuscular Disorders
·
3
Clinical Trial Highlights
2021
·
E. Hoffman
, U. Dang
, et al.
·
Neuromuscular Disorders
·
1
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2
2026
·
Carla F. Bolano-Diaz
, Jose Verdu-Diaz
, et al.
·
Journal of Neurology
PDF
357P Correlation between height, weight, and body mass index z-scores and clinical outcome assessments in young boys with Duchenne muscular dystrophy
2024
·
M. Schiava
, U. Dang
, et al.
·
Neuromuscular Disorders
POSC133 Use of Expert Elicitation to Extrapolate Observed Intermediate Clinical Trial Outcomes to Clinically Meaningful Long-Term Outcomes for Use in Health Technology Assessments: A Case Study in a Rare, Lifelong Disease
2022
·
R Evans
, A Williams
, et al.
·
Value in Health
DMD - TREATMENT
2021
·
E. Hoffman
, U. Dang
, et al.
·
Neuromuscular Disorders
Show more works
View as search
Works count:
8
Citation count:
13
H-index:
3
I10-index:
Year
Topic
Type